MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Year: 2007
Type: article
Study design: Observational Study
Source: Molecular Cancer Therapeutics
Authors: James Bean, Cameron Brennan, Jin-Yuan Shih, Gregory J. Riely, Agnès Viale, Lu Wang, Dhananjay Chitale, Noriko Motoi, János Szőke, Stephen Broderick, Marissa N. Balak, Wen-Cheng Chang, Chong‐Jen Yu, Adi F. Gazdar, Harvey I. Pass, Valerie W. Rusch, William L. Gerald, Shiu-Feng Huang, Pan‐Chyr Yang, Vincent A. Miller, Marc Ladanyi, James Chih‐Hsin Yang, William Pao
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2304781427